Skip to main content
$149.45 -$12.79 (-7.9%)

04:00 PM EST on 02/25/21

Guardant Health Inc (NASDAQ:GH)

CAPS Rating: 5 out of 5

Current Price $149.45 Mkt Cap $16.2B
Open $154.00 P/E Ratio 0.00
Prev. Close $149.45 Div. (Yield) $0.00 (0.0%)
Daily Range $146.00 - $154.97 Volume 2,967,145
52-Wk Range $55.90 - $181.07 Avg. Daily Vol. 1,144,993

Caps

How do you think NASDAQ:GH will perform against the market?

Add Stock to CAPS Watchlist

All Players

360 Outperform
2 Underperform
 

All-Star Players

235 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:GH Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFEBCapital (98.62)
Submitted April 22, 2019

Q4 revenue of $32.9 million, up 64%, and FY2018 rev. of $90.6 million, up 82% YoY hints at multibillion opportunity associated with disrupting tissue biopsy genetic discovery. Growing use of liquid biopsy test in solid tumor cancer = FY 2019 revenue… More

CMFTomato (97.76)
Submitted March 20, 2019

High-flyer! Long-term, Guardant Health is doing fascinating things in oncology and there is a tremendous addressable market for their diagnostic offerings, but the story is nearing the top of a hype cycle and with the April 2 lockup expiration… More

NASDAQ:GH VS S&P 500 (SPY)

NASDAQ:GH Summary

Fools bullish on NASDAQ:GH are also bullish on:

Fools bearish on NASDAQ:GH are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about GH.

Recs

0
Member Avatar SadLyzer (32.28) Submitted: 1/29/2021 4:53:48 PM : Outperform Start Price: $155.31 NASDAQ:GH Score: -6.08

Big potential. Telemedicine is more and more important. Could be game changer.

Recs

0
Member Avatar TMFacarchidi (41.77) Submitted: 11/5/2020 1:59:26 PM : Outperform Start Price: $115.87 NASDAQ:GH Score: +20.21

Good revenue growth, a compelling oncology product, and highly flexible leadership.

Recs

0
Member Avatar tomfoolme (75.86) Submitted: 10/14/2020 6:28:11 AM : Outperform Start Price: $109.82 NASDAQ:GH Score: +27.08

Guardant Health, Inc. is a precision oncology company, which engages in treatment of cancer through use of proprietary blood-based tests, vast data sets, and advanced analytics. 10B. Pe:- div-. Fool rec.

Leaderboard

Find the members with the highest scoring picks in GH.

Score Leader

jmaleki333

jmaleki333 (< 20) Score: +340.00

The Score Leader is the player with the highest score across all their picks in GH.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
jmaleki333 < 20 10/11/2018 Outperform 5Y $31.26 +378.09% +38.09% +340.00 0 Comment
drum1234 49.01 12/24/2018 Outperform 5Y $33.51 +345.99% +59.94% +286.04 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. clickme999 97.04 1/4/2019 Outperform 5Y $34.82 +329.21% +54.42% +274.79 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. lcod 76.88 12/3/2018 Outperform 5Y $36.70 +307.22% +36.41% +270.81 0 Comment
baller89 98.10 11/30/2018 Outperform 5Y $36.78 +306.33% +39.30% +267.04 0 Comment
Wakanda 99.92 11/21/2018 Outperform 5Y $36.60 +308.33% +43.26% +265.07 0 Comment
Darthtaco 91.71 1/4/2019 Outperform 5Y $35.97 +315.49% +51.76% +263.72 0 Comment
TMFProcess 94.20 12/20/2018 Outperform 5Y $35.84 +316.99% +54.02% +262.97 0 Comment
joaopsmartins 97.55 12/28/2018 Outperform 5Y $35.92 +316.06% +53.19% +262.87 0 Comment
esusatyo 97.64 12/18/2018 Outperform 5Y $36.49 +309.56% +48.65% +260.91 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for GH.